Pravastatin Attenuates Lower Torso Ischaemia–Reperfusion-induced Lung Injury by Upregulating Constitutive Endothelial Nitric Oxide Synthase  by Joyce, M. et al.
Eur J Vasc Endovasc Surg 21, 295–300 (2001)
doi:10.1053/ejvs.2001.1318, available online at http://www.idealibrary.com on
Pravastatin Attenuates Lower Torso Ischaemia–Reperfusion-
induced Lung Injury by Upregulating Constitutive Endothelial
Nitric Oxide Synthase
M. Joyce, C. J. Kelly∗, G. Chen and D. J. Bouchier-Hayes
Department of Surgery, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland
Objectives: to elicit whether pre-treatment with pravastatin will prevent or ameliorate the acute lung injury that occurs
following lower torso ischaemia–reperfusion (IR) in an experimental animal model.
Materials and methods: male Sprague–Dawley rats were randomised into three groups (n=7/group). The control
group underwent a sham laparotomy and aortic dissection. The second group underwent infrarenal aortic cross clamping
for 30 min followed by reperfusion for 120 min. The third group pre-treated with pravastatin sodium (0.4 mg/kg/day over
5 days) were again subjected to an ischaemia–reperfusion (IR) injury. The parameters used to assess lung injury included:
Wet to dry lung weight ratio (W:D), myeloperoxidase activity (MPO), protein concentration (BALprot) and neutrophil
count (BAL PMN) of bronchoaveolar lavage fluid. Western blotting was used to determine the expression of constitutive
endothelial nitric oxide synthase (ecNOS) within lung tissue.
Results: IR causes an acute lung injury as indicated by statistically significant differences in W:D lung weight ratios,
MPO activity, neutrophil count and BALprotein concentration in the IR group over that of controls. Pre-treatment with
pravastatin attenuated this neutrophil infiltration and microvascular leakage. The pravastatin group showed a marked
increased expression of ecNOS over that of the IR group and controls.
Conclusion: this data indicates that pre-treatment with pravastatin protects against ischaemia–reperfusion induced lung
injury in an experimental animal model. We believe that its mechanism of action involves an upregulation of ecNOS,
which increases basal expression of nitric oxide providing protective effects on the pulmonary circulation against
microvascular injury.
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Introduction disease and hypercholesterolaemia.7–10 However, a
number of in vitro experiments have shown they
Ischaemia–reperfusion injury, an inevitable com- have direct vascular effects, improving endothelium-
ponent of aortic reconstruction surgery, may result dependent relaxation by increasing ecNOS pro-
in neutrophil mediated distal organ damage.1,2 The duction and activity, even under hypoxic conditions.11
U.K. small aneurysm trial has recently reported that Kaesemeyer et al. demonstrated that pravastatin
pulmonary dysfunction is still a major cause of stimulated vasorelaxation in aortic rings. Removal
morbidity and mortality in patients undergoing of the endothelium obliterated this response, in-
elective abdominal aortic aneurysm surgery.3 The dicating the endothelial cell-dependency of the pra-
ensuing lung injury characterised by increased micro- vastatin effect.12 Clinically, statins have been shown
vascular permeabilty and neutrophil infiltration may to improve endothelial dysfunction in hyper-
result in non-cardiogenic pulmonary oedema.4,5 cholesterolaemic patients within 1 month of treat-
Statins competively inhibit HMG-CoA reductase, ment, an effect which did not correlate directly with
the enzyme that catalyses the rate limiting step in the decrease in serum cholesterol.13
cholesterol biosynthesis.6 Clinical trials have proven With this emerging evidence for a direct vascular
that they reduce cardiovascular-related morbidity and effect, the aim of our experiment was to elicit whether
mortality in patients with established cardiovascular pre-treatment with pravastain would prevent or
ameliorate the acute lung injury induced by lower
torso ischaemia–reperfusion in an experimental∗ Please address all correspondence to: C. J. Kelly, Professorial Unit,
Department of Surgery, Beaumont Hospital, Dublin 9, Ireland. animal model.
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Materials and Methods after which the pulmonary vasculature of the left
lung was washed out with 50 ml of normal saline.
Animal preparation A section of the left lung was removed and weighed,
prior to homogenisation, in 0.5% hexadecyl trimethyl
Twenty-one male Sprague–Dawley (Harlem, U.K.) ammonium bromide (HTAB) in 50 mmol/l potassium
phosphate buffer at pH6. The supernatant wasrats weighing 300–400 g were randomised into three
groups: the control group, I-R group and I-R group assayed spectrophotometrically for MPO activity.
One unit of MPO was defined as that degrading 1pre-treated with pravastatin. The pravastatin sodium
0.4 mg/kg/day (Bristol Meyer Squibb Phar- micromole of peroxide per minute at 25 oc and
calculated per gram of tissue.15,16maceuticals) was gavaged in 1 ml of distilled water,
in a single daily dose for 5 days, prior to laparotomy.
The non-pravastatin groups were similarly gavaged
with 1 ml of distilled water.
Neutrophil concentration of bronchoalveolar fluidAnimals were maintained on a diet of purified
chow pellet and water. They were anaesthetised
Two hundred microlitres of BALfluid were removedusing inhalational halothane. They were maintained
and the neutrophil concentration obtained by Diff-supine for the duration of the experiment, kept
Quick staining. This was then expressed as thewarm using an infrared light and core body tem-
number of neutrophils per high power field.17,18perature was measured using a rectal temperature
probe. Experimentation was performed under licence
from the Department of Health, Republic of Ireland.
Wet:dry lung weight ratio
The wet:dry lung weight ratio of the right lower
Ischaemia–reperfusion model lobe was calculated after weighing the freshly har-
vested organ and heating it at 90 °C in a gravity
All rats including controls underwent a midline convection oven over a 72-h period until such time
laparotomy and aortic dissection. Ischaemia was as the weight of the remaining residue was found
induced by cross-clamping the infrarenal aorta for to be constant.17,18
30 min using a microvascular clamp; this was fol-
lowed by 120 min of reperfusion. Occlusion and
reperfusion were confirmed by use of a Doppler
Western immunoblotting for ecNOS expressionultrasound probe placed distal to the site at which
the microvascular clamp was placed. A tracheostomy
Following intravascular washout a section of the leftwas performed using a 16 gauge intravenous cannula
lung was harvested and snap frozen in liquidfor the purpose of bronchoalveolar lavage (BAL).
nitrogen. Prior to analysis the tissue sample wasFollowing sternotomy the left main bronchus and
thawed, then homogenised in cold phosphate bufferright lower lobe was clamped. Lavage was performed
saline (1 ml) and centrifuged at 4100 g for 30 min aton the right lung using 2 ml saline containing 0.07 M
4 °C. The supernatants were collected and proteinEDTA, and repeated. This lavage fluid was cold-
concentration was quantified using a Coomasie pro-centrifuged at 1500 g for 20 min, frozen at −20 °C
tein assay reagent (Rockfield, Illinois, U.S.A). Theand subsequently assayed for protein concentration
final protein concentration of samples was dilutedvia the spectrophotometric dye method of Lowry et
to 50 g/10 l. The proteins were denatured at 100 °Cal.14
for 10 min and aliquots containing equal amount of
protein were then suspended in sodium dodecyl
sulphate (SDS)-glycerol loading buffer (Ph 6.8,
62.5 mmol/l Tris, 2% SDS, 10% glycerol, 5% mer-Myeloperoxidase assay
captoethanol, 0.01% bromophenol blue), and proteins
were separated by SDS-PAGE (polyacrylamide gelMyeloperoxidase is a haem-containing enzyme,
which is found in neutrophils and so can be used elecrophoresis) (ExcelGel, Pharmacia, Sweden) with
75 g total protein per lane.19 Proteins were thenas an indirect measure of tissue neutrophil infiltration.
The right ventricle was cannulated with a 25 G transferred to a nitrocellulose membrane (Sigma)
and labelled with a primary monoclonal antibody,needle and the right pulmonary hilum clamped,
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mouse antirat IgG1, specific for e-NOS (StressGen,
Victoria, British Columbia). After the second mono-
clonal antibody was added, sheep antimouse IgG1
conjugated with alkaline phosphatase (Serotec,
Oxford, England), the protein was visualised using
bromochloroindolyl phosphate/nitro blue tetra-
zolium (BCIP/NBT, Sigma). Following western blot-
ting, quantification of eNOS detected was performed
using densiometry (GeneSnap, Syngene).
Serum cholesterol levels
During cannulation of the right ventricle and prior
to pulmonary vasculature washout a sample of blood
was obtained to assess lipid profile.
Fig. 1. Effect of ischaemia–reperfusion on pulmonary myelo-
peroxidase activity. Horizontal lines=group means. ∗p<0.01 vs con-
trol; # p<0.01 vs IR (Scheffe post hoc test).
Statistical analysis
with controls, as determined by wet:dry lung weight
Data are expressed as the mean (s.e.m.), in text and measurements and BALprot concentration. W:D
figures. Results were analysed using one-way analysis weight ratios and BAL prot concentrations increased
of variance for the comparison of multiple means from control values of 4.96(0.23) and 159.32(36.27) g/
(ANOVA) with post hoc Scheffe test analysis. ml to ischaemia–reperfusion values of 7.63(0.31) and
Statistical significance was set at p<0.01. 544.87(38.55) g/ml (p<0.01 ANOVA).
Again, pre-treatment with pravastatin resulted
in statistically significant reductions in W:D ratios
5.72(0.46) and BALprot concentrations 362.29(41.14)Results
g/m (p<0.01 ANOVA) (Figs 2, 3).
Pulmonary neutrophil infiltration
ecNOS expressionIschaemia reperfusion resulted in an increase in
neutrophil infiltration over that of controls as meas-
Administration of pravastatin was associated withured by BAL PMN counts and MPO activity within
increased expression of ecNOS over that of thelung tissue. BAL PMN counts went from a control
controls and ischaemia–reperfusion group. The bandvalue of 4.94(1.27)/high power field to IR value
intensity value for the pravastatin group was 1.7of 26.12(3.2)/high power field (p<0.01 ANOVA).
times that of the IR-group and 1.08 times that ofSimilarly, MPO activity went from a control value
the control group. (Fig. 4.)of 4.97(0.49)units/g to 7.67(0.51)units/g in the I-R
group (p<0.01 ANOVA).
Pre-treatment with pravastatin resulted in sig-
nificant reductions in BAL PMN counts 9.8(1.42)/ Serum cholesterol levels
high power field and MPO activity 5.7(0.28)units/
g compared with the ischaemia–reperfusion group No statistically significant differences were observed
(p<0.01 ANOVA) (Fig. 1). for any of the lipid parameters across all groups.
DiscussionPulmonary microvascular leakage
The aim of the study was to determine if pravastatinIschaemia–reperfusion resulted in a significant in-
crease in pulmonary microvascular leakage compared would attenuate the acute lung injury that occurs
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Once again the model demonstrates that infrarenal
aortic occlusion followed by a period of reperfusion
may result in distal organ damage, particularly acute
lung injury. However, the study shows that pre-
treatment with pravastatin will ameliorate this
neutrophil infiltration and microvascular leakage
with upregulation of ecNOS being the potential
mechanism of protection.
Activated neutrophils play a key role in mediating
local plus distal organ damage following ischaemia–
reperfusion.4,20–22 Neutrophil adherence to endo-
thelium is a prerequisite of PMN migration through
the vascular wall and subsequent accumulation
within ischaemic tissue. These interactions are fa-
cilitated by the expression of adhesion molecules on
the surface of the vascular endothelium and circu-
Fig. 2. Effect of ischaemia–reperfusion on wet to dry lung weight lating cells. On transendothelial migration the neutro-
ratios. Horizontal lines=group means. ∗ p<0.01 vs control; # p<0.01 phil generates reactive oxygen species and proteolytic
vs IR (Scheffe post hoc test).
enzymes. These superoxide free radicals lead to a
downregulation of nitric oxide (NO) production and
loss of its beneficial effects to the endothelium.23 A
wide variety of agents have been utilised to try
and modify this neutrophil-mediated phenomenon.
Kearns et al. showed that the antioxidant vitamin C
attenuated this injury, while Javadpour et al. found
that thermal preconditioning provided a protective
effect by increasing the expression of heat shock
proteins, highlighting that acute lung injury sec-
ondary to lower torso ischaemia reperfusion may be
modified by therapeutic intervention.18,24 In this acute
lung injury model pre-treatment with pravastatin
significantly attenuated neutrophil infiltration and
thus showed the potential for generation of reactive
oxygen species and parenchymal lung damage. This
would be consistent with in vitro models showing
melvalonate-dependent inhibition of transendothelial
migration and chemotaxis of peripheral blood neutro-
phils by pravastatin.25Fig. 3. Effect of ischaemia–reperfusion on bronchoalveolar lavage
Statins also have direct beneficial effects on theprotein concentration. Horizontal lines=group means. ∗ p<0.01 vs
control; # p<0.01 vs IR (Scheffe post hoc test). vascular endothelium that involve an upregulation
in the expression and activity of ecNOS.11,12 This
enzyme catalyses the conversion of L-arginine to
nitric oxide with citrulline as the other reaction
product. Under physiological conditions nitric oxide
has important vasomotor and thromboregulatory
Fig. 4. Western blot analysis of ecNOS expression in the lung tissue, effects but its production is impaired in ischaemia–
demonstrating an upregulation in the pre-treated group subjected
reperfusion.26 In the above experiment pre-treatmentto ischaemia–reperfusion injury.
with pravastatin attenuated the pulmonary per-
meability induced following ischaemia–reperfusion
by upregulating ecNOS, which produces nitric oxidefollowing lower torso ischaemia–reperfusion and to
and preserves vascular endothelial integrity.elicit if beneficial effects on pulmonary vasculature
It is possible that the results of this study mayinvolved upregulation of ecNOS as demonstrated
previously in vitro.11,12 not translate into clinical benefits due to species
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neutrophil-related acute lung injury after intestinal ischemiavariability. We also appreciate that we are dealing
reperfusion. Surgery 1989; 106: 195–202.with healthy rats as opposed to the clinical scenario 5 Paterson IS, Klausner JM, Pugatch R et al. Non-cardiogenic
in which patients may have severe vascular disease pulmonary oedema after abdominal aortic aneurysm surgery.
Ann Surg 1989; 209: 231–236.and other co-existing pathology. However, the bulk
6 Endo A, Tsujita Y, Kuroda M et al. Inhibition of cholesterolof the evidence would suggest that effects of statins synthesis in vitro and in vivo by ML-236A and ML-236B,
on endothelium demonstrate interspecies preserv- competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme
A reductase. Eur J Biochem 1977; 77: 31–36.ation. We have known for many years that prava-
7 Scandinavian Simvastatin Survival Study investigators.statin reduces cardiovascular-related mortality.8,9 Randomized trial of cholesterol lowering in 4444 patients with
These cardioprotective effects were reproducible in an coronary heart disease: the Scandinavian Simvastatin Survival
Study (4S). Lancet 1994; 344: 1383–1389.animal model of myocardial ischaemia–reperfusion.27
8 Shepherd J, Cobbe S, Ford I et al. Prevention of coronaryStatins have also been shown to reduce the size of heart disease with pravastatin in men with hy-
cerebral infarction in a murine stroke model by the percholesterolemia: West of Scotland Coronary Prevention
Study. N Engl J Med 1995; 333: 1301–1307.upregulation of ecNOS, which augments cerebral
9 Byington RP, Jukema JW, Salonen JT et al. Reduction inblood flow. The beneficial effects were absent in cardiovascular events during pravastatin therapy. Circulation
eNOS deficient mice, indicating the importance of 1995; 92: 2419–2425.
10 Rosenson RS, Tangney CC. Antiatherothrombotic propertiesthe L-arginine nitric oxide synthase pathway.28 This
of statins: implications for cardiovascular event reduction.correlates with evidence that statins reduce the risk
JAMA 1998; 279: 1643–1650.
of stroke in patients who are hypercholesterolaemic, 11 Laufs U, Fata VL, Plutzky J, Liao JK. Upregulation of
endothelial nitric oxide synthase by HMG CoA Reductasebut also in patients with normal cholesterol levels.29
inhibitors. Circulation 1998; 97: 1129–1135.However, further investigation and clinical trials will
12 Kaesemeyer WH, Caldwell RB, Huang J, Caldwell RW.
be required to determine if the beneficial effects Pravastatin sodium activates endothelial nitric oxide synthase
independent of its cholesterol-lowering actions. J Am Collof pravastatin observed in our animal model are
Cardiol 1999; 33: 234–241.applicable to clinical use.
13 O’Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-In conclusion, this study shows that pre-treatment coenzyme a reductase inhibitor, improves endothelial function
with pravastatin attenuates ischaemia–reperfusion- within 1-month. Circulation 1997; 95: 1126–1131.
14 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Proteininduced lung injury with a potential mechanism of
measurement with the Folin phenol reagent. J Biol Chem 1951;action involving the upregulation of ecNOS. Thus, 193: 265–275.
pravastatin, which has traditionally been used in the 15 Williams RN, Paterson CA, Eakins KE et al. Quantification
of ocular inflammation: evaluation of polymorphonuclear leuco-management of dyslipidaemia, may have potential
cyte infiltration by measuring myeloperoxidase activity. Currclinical applications in the pre-treatment of patients Eye Res 1983; 2: 465–470.
undergoing elective vascular procedures where there 16 Bradley PP, Priebrat DA, Christensen RD, Rothstein
G. Measurements of cutaneous inflammation: estimation ofis the potential for microvascular injury.
neutrophil content with an enzyme marker. J Invest Dermatol
1982; 78: 206–209.
17 Barry MC, Kelly CJ, Stokes K et al. Glyceryl trinitrate
prevent neutrophil activation but not thromboxane release
following ischaemia–reperfusion injury. Br J Surg 1996; 83:Acknowledgements
1095–1100.
18 Javadpour M, Kelly CJ, Chen G et al. Thermotolerence
The authors acknowledge the assistance of D. Borwick, M. Dunphy induces heat shock protein 72 expression and protects against
and C. Condron of the Biomedical Research Facility, Beaumont ischaemia–reperfusion-induced lung injury. Br J Surg 1998; 85:
Hospital, Dublin, in preparation of the above work. This project 943–946.
was supported by a grant from the Royal College of Surgeons, 19 Liao JK, Shin WS, Lee WY et al. Oxidized low-density
Beaumont Hospital, Dublin 9, Ireland. lipoprotein decreases the expression of endothelial nitric oxide
synthase. J Biol Chem 1995; 270: 319–324.
20 Welbourn CRB, Goldman G, Paterson IS et al. Neutrophil
elastase and oxygen radicals: synergism in lung injury after
hindlimb ischaemia. Am J Physiol 1991; 260: H1852–H1856.
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